News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Charles Jeffrey Tan: I’m Starting a New Position as Drug Development and Phase 1 Clinical Trial Fellow at Princess Margaret Cancer Centre
Charles Jeffrey Tan/LinkedIn
Jul 5, 2025, 06:46

Charles Jeffrey Tan: I’m Starting a New Position as Drug Development and Phase 1 Clinical Trial Fellow at Princess Margaret Cancer Centre

Charles Jeffrey Tan, Drug Development and Phase 1 Clinical trial Fellow at Princess Margaret Cancer Centre, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Drug Development and Phase 1 Clinical trial Fellow at Princess Margaret Cancer Centre!”

cancer Charles Jeffrey Tan drug development OncoDaily Oncology Princess Margaret Cancer Centre
Special Coverage
Voices
Sep 5, 2025, 12:59
Fabio Ynoe de Moraes: Two Very Different Stories are Emerging About AI in Research
Insight
Sep 5, 2025, 12:58
Gianluca Franceschini: Inside the Integrated Breast Center of Gemelli Polyclinic
Voices
Sep 5, 2025, 12:51
How a Clinical Trial Gave Molly a Second Chance at Life - Conquer Cancer, the ASCO Foundation
Insight
Sep 5, 2025, 12:31
Courtney Jones: A New Publication From the Lab in Blood
Voices
Sep 5, 2025, 12:12
Jennifer Sullivan: Bringing "The Best of What We Are Wherever You Are"
Voices
Sep 5, 2025, 12:06
Armando Orlandi: Extraordinary Success for the 17th Breast Club!
Voices
Sep 5, 2025, 11:58
Roupen Odabashian: How WorkDone Health Tackles a $125B Healthcare Problem
Insight
Sep 5, 2025, 11:56
Eric Small on FY26 Budget: Saving Research Means Saving Lives
Voices
Sep 5, 2025, 11:45
Annalice Gandini: A Case Report on the Successful Use of Dual EGFR Blockade
Voices
Sep 5, 2025, 11:43
Conquering Underfunded and Rare Cancers Through Research - Conquer Cancer, the ASCO Foundation
Science
Sep 5, 2025, 11:34
Harpreet Singh: FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant NSCLC
Voices
Sep 5, 2025, 11:26
Jia (Jenny) Liu: Excited to Share that NECTA PANNA-COTA Trial Reaches 100 Patients Enrolled